Pearlium®/Effecti-Cal®, a Novel Formulation of Calcium, Vitamin D and Minerals for Prevention of Postmenopausal Bone Loss
Clinical trial NCT04609189 · COMPLETED
Trial details
- NCT number
- NCT04609189
- Sponsor
- University of Alberta
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-12
- Primary completion
- 2014-05-02
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.